Drug Discovery

#Drug discovery #Microbiome #Synthetic biology

Stanford researchers construct the most complete synthetic microbiome

Listen to this article on the DDW Podcast: Rebecca McClellan, Scientific Program Manager, Research, Development & Communications, explains how scientists are learning more about the connections between the microbiome and human health to potentially develop first-in-class microbiome therapies. Key studies in the last decade have shown that the gut… Read More

#Exclusive Content

#cryo-microscopy #Drug discovery #Proteins #Webinar

Webinar: Discover the implications of atomic resolution cryo-EM

Join DDW for this exclusive free event High resolution electron cryo-microscopy: From membrane proteins to diseases, supported by Thermo Fisher Scientific, which will take place on 19 October, 2022, 4PM BST, 8AM PDT. Discover how cryo-EM is impacting high resolution structure biology from membrane proteins… Read More

#News

#Drug discovery #Peptides #Reagents #Video

Video: Where chemistry meets biology and products meet services

Biosynth are experts in complex chemistry, peptides and key biological raw materials, providing more than half a million research products plus end-to-end manufacturing including discovery, optimisation, and scale up. Biosynth manufacture and source a vast range of chemical and biochemical products and provide a full range of products… Read More

#News

#Contract development and manufacturing organisations #Drug discovery #Manufacturing #Pharmaceuticals

Maximising outsourcing models beyond time and cost

In this listicle, SAMDITech outlines the benefits of outsourcing models in the pharmaceutical industry, looking past perceived costs to the value outsourcing can bring.   Many biotech and pharmaceutical companies now  rely on contract research organisations (CROs) for drug discovery services. CROs offer an established infrastructure to develop, initiate, execute,… Read More

#News

#Automation / robotics #Biotechnology #Drug discovery #Drug screening #ELRIG #Events #Life sciences

Comment: Join the science revolution at Drug Discovery 2022 

ELRIG CEO Sanj Kumar tells readers how they can access the most exciting research and find the latest technologies to propel their projects forward at this year’s Drug Discovery 2022  At ELRIG, our purpose is to support researchers in the life sciences and drug discovery communities to learn, share,… Read More

#Exclusive Content #Opinion

#Biopharmaceuticals #Drug development #eBook #LC-MS

eBook – LC-MS Analysis for (Bio)pharmaceutical Research

This is the seventh eBook of the Hamilton series “LC-MS Analysis for (Bio)pharmaceutical Research”. This ebook covers: The role of LC-MS in the drug development process The drivers behind the need for LC-MS sample prep automation in biopharma The modules and full liquid handling automation solutions that Hamilton offers… Read More

#News

#Biopharmaceuticals #Drug development #Liquid handling #Research

LC-MS Analysis for (Bio)pharmaceutical Research

In the seventh eBook of the Hamilton series “LC-MS Analysis for (Bio)pharmaceutical Research”, we discuss: The role of LC-MS in the drug development process The drivers behind the need for LC-MS sample prep automation in biopharma The modules and full liquid handling automation solutions that Hamilton offers for LC-MS… Read More

#Intelligence #Resources

#Drug discovery #Fragment-based drug discovery #Hit identification

Webinar: Introduction into Fragment Based Drug Discovery

Fragment-based drug discovery (FBDD) is one strategy of hit identification (hit ID) in the drug discovery process. Watch the webinar, Introduction into Fragment Based Drug Discovery, hosted by DDW and supported by WuXi AppTec. Key Learning Objectives:   How FBDD can help identify novel and potent lead… Read More

#News

#AI / data analytics / healthtech / informatics #Biopharmaceuticals #Drug discovery #Healthcare

How AI in pharma can live up to the hype 

Listen to this article on the DDW Podcast: Ben Folwell, Principal Consultant at Citeline, maps out how AI, swarm learning and open access to clinical data could revolutionise drug discovery.  Artificial intelligence (AI) is notorious for its industry hype, touted to revolutionise the way multiple sectors… Read More

#Business & Investment #Exclusive Content #Opinion #Trends & Analysis

#cryo-microscopy #Drug discovery #Proteins #Webinar

Webinar: High resolution electron cryo-microscopy

Join DDW for this exclusive free event High resolution electron cryo-microscopy: From membrane proteins to diseases, supported by Thermo Fisher Scientific.   It will take place on 19 October, 2022, 4PM BST, 8AM PDT. Register free here.  The aim of… Read More

#News

#AI #AI / data analytics / healthtech / informatics #Automation / robotics #Drug discovery #Drug Discovery 2022 #ELRIG

DDW Fall 2022 issue out with Drug Discovery 2022 supplement

The Fall Issue of the Drug Discovery World Magazine is out now.   Featuring Specialty Spotlight on Neuroscience, the magazine is available to download and read for free on the DDW App.   Key features of the Fall Issue include How AI in Pharma Can Live Up… Read More

#News

#AI #Biotechnology #Collaboration #Drug discovery #Pfizer

Pfizer and CytoReason collaborate to bolster AI in drug discovery

Pfizer has extended its multi-year partnership with CytoReason to use CytoReason’s artificial intelligence (AI) technology for Pfizer’s drug development programs.   Pfizer will make a $20 million equity investment, have options to license CytoReason’s platform and disease models, and fund supplementary project support. This deal which has the potential to be… Read More

#Business & Investment #News

Chinese flag
#Biotechnology #Drug development #Drug discovery #Podcast

Podcast: China’s opportunities for global drug discovery breakthroughs

This is the latest episode of the free DDW podcast, “China’s opportunities for global drug discovery breakthroughs”. It covers three articles written for Volume 22, Issue 4 – Fall 2021 of DDW, narrated by DDW Multimedia Editor Megan Thomas. They are called “Is China entering a new phase for… Read More

#News

Automation
#AI #Automation / robotics #Drug discovery #Sustainability

How can automation help in the discovery of biologics?

Zoe Hughes-Thomas, GSK, will be discussing the ways in which Automation Can Help With The Discovery of Biologics and Biosimilars at the new Tech Theatre at this year’s ELRIG Drug Discovery, supported by DDW. Hughes-Thomas is Associate Director, Head Medicine Design Automation, GSK. The Tech… Read More

#Editor's Choice #News

#Drug discovery #Fragment-based drug discovery #Hit identification

Discover the benefits of fragment-based drug discovery

Watch the free webinar, Introduction into Fragment Based Drug Discovery, hosted by DDW and supported by WuXi AppTec. Fragment-based drug discovery (FBDD) is a method used for finding hit compounds as one strategy of hit identification (hit ID) in the drug discovery process. Fragments are small molecules… Read More

#News

Antibody
#Drug discovery #Monoclonal antibodies #Webinar

Webinar: Octet BLI for antibody discovery

Join DDW & Charles River Laboratories in this free webinar examining how the company uses Octet Bio-Layer Interferometry (BLI) to help inform its drug discovery campaigns and workflows. In this webinar, Christina Pettus, Senior Scientist, Charles River Laboratories, provides insights into how the company incorporates Octet Bio-Layer Interferometry (BLI) into… Read More

#News